BRIEF-Valeant Pharmaceuticals announces licensing agreement with Norgine B.V. for NER1006 in U.S. and Canada

Mon Aug 8, 2016 8:38am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 8 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant pharmaceuticals announces licensing agreement with Norgine B.V. For NER1006 in U.S. and Canada

* Norgine will manufacture and supply NER1006 for Valeant

* Valeant Pharmaceuticals announces licensing agreement with Norgine B.V. for NER1006 in U.S. and Canada

* Financial terms of agreement have not been disclosed. Source text for Eikon: Further company coverage: